Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Colorectal Cancer: Individualizing Treatment, Improving Outcomes
EP. 1: Deciding on Adjuvant Therapy in CRC
February 26th 2018
EP. 2: Duration of Adjuvant Therapy: CRC Subsets
February 26th 2018
EP. 3: Managing Patients After Adjuvant Therapy
February 26th 2018
EP. 4: Treating Liver or Peritoneal Metastases in CRC
February 26th 2018
EP. 5: Early-Onset CRC: What Do We Know?
February 26th 2018
EP. 6: Role of Molecular Testing in CRC Management
February 26th 2018
EP. 7: Importance of HER2 Expression in CRC
February 26th 2018
EP. 8: Left- Versus Right-Sided Tumors in CRC
February 26th 2018
EP. 9: Frontline Antibody Selection in Metastatic CRC
February 26th 2018
EP. 10: Maintenance and Second-Line Decisions in CRC
February 26th 2018
EP. 11: Supportive Care in Metastatic CRC
February 26th 2018
EP. 12: Immunotherapy Options in Refractory CRC
February 26th 2018
EP. 13: Third-Line Treatment in Refractory CRC
February 26th 2018
EP. 14: Dosing and Side Effect Management in Metastatic CRC
February 26th 2018
EP. 15: Managing Toxicities With Immunotherapy in CRC
February 26th 2018
EP. 16: Emerging Immunotherapy Combinations in MSS CRC
February 26th 2018
EP. 17: Progress in CRC Precision Medicine
February 26th 2018
EP. 18: Improving Outcomes in CRC
February 26th 2018